King Saud University

Running trials

• Recruiting

  Levetiracetam Three Times Daily in Epilepsy

  NCT07490769· Phase 3· Source

• Active, not recruiting

  A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab

  NCT06880744· Phase 3· Source

• Recruiting

  An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis

  NCT06764693· Source

• Active, not recruiting

  A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease.

  NCT06063967· Phase 3· Source

• Active, not recruiting

  A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus

  NCT05531565· Phase 2/3· Source

• Active, not recruiting

  A Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (Peginterferon Beta-1a) in Pediatric Participants for the Treatment of Relapsing-Remitting Multiple Sclerosis

  NCT03958877· Phase 3· Source

• Recruiting

  Prospective Urban Rural Epidemiology Study

  NCT03225586· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Epilepsy1 recruiting
• Psoriasis1 recruiting
• Psoriatic arthritis1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan

  NCT06635057· Phase 4· Source

• Completed

  Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction

  NCT00673842· Phase 3· Source

Trial sites

• King Saud University6 trials
• King Saud University /ID# 2645361 trial
• King Saud University /ID# 2748181 trial
• King Saud University /ID# 2794631 trial

Conditions

Diseases this institution publishes on or runs trials for.

• Obesity169 works · 0 trials
• Type 2 diabetes93 works · 1 trials
• Autism44 works · 0 trials
• Multiple sclerosis34 works · 1 trials
• Fatty liver disease (MASLD/MASH)29 works · 0 trials
• Rheumatoid arthritis27 works · 0 trials
• Diabetic eye disease25 works · 0 trials
• Osteoporosis23 works · 0 trials
• Type 1 diabetes20 works · 0 trials
• Glaucoma20 works · 0 trials
• Psoriasis20 works · 1 trials
• Migraine15 works · 0 trials
• Sickle cell disease12 works · 0 trials
• Ankylosing spondylitis9 works · 0 trials
• Thalassaemia5 works · 0 trials
• Fabry disease3 works · 0 trials